Age-related clinical characteristics of children and adolescents with ADHD.
ADHD symptoms
adolescents
anxiety
children
depression
emotional dysregulation
functional impairment
hyperactivity
Journal
Frontiers in psychiatry
ISSN: 1664-0640
Titre abrégé: Front Psychiatry
Pays: Switzerland
ID NLM: 101545006
Informations de publication
Date de publication:
2023
2023
Historique:
received:
14
10
2022
accepted:
10
01
2023
entrez:
13
2
2023
pubmed:
14
2
2023
medline:
14
2
2023
Statut:
epublish
Résumé
Attention deficit hyperactivity disorder (ADHD) has been associated with difficulties in regulating aversion states, high functional impairment, and a high risk of psychopathology across the lifespan. ADHD is clinically heterogeneous, with a wide spectrum of severity and associated symptoms. Clinical characteristics need to be carefully defined in different periods of life as ADHD course, symptoms, and comorbidities may fluctuate and change over time. Adolescence usually represents the transition from primary to secondary education, with a qualitative and quantitative change in environmental and functional demands, thus driving symptoms' change. In order to characterize age-related clinical features of children (<11 years) and adolescents (≥11 years) with ADHD, we conducted a naturalistic study on 750 children and adolescents assessed for ADHD at our Neuropsychiatry Unit over the course of 3 years (2018-2020). We found that ADHD symptoms were significantly higher in children than adolescents. More importantly, we found worse global functioning, lower adaptive skills, higher levels of anxiety and depressive symptoms, somatic complaints, emotional dysregulation, social problems, and aggression in adolescents, despite a lower severity of ADHD-specific symptoms. These results should be confirmed in longitudinal observational studies of adequate sample size in order to reliably describe a potential course characterized by worsening of functioning, reduction in ADHD-specific symptoms and increase in general psychopathology during the transition from childhood to adolescence.
Identifiants
pubmed: 36778635
doi: 10.3389/fpsyt.2023.1069934
pmc: PMC9911799
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1069934Informations de copyright
Copyright © 2023 De Rossi, D’Aiello, Pretelli, Menghini, Di Vara and Vicari.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
J Atten Disord. 2017 Jan;21(1):3-13
pubmed: 25501355
Am J Psychiatry. 2007 Jun;164(6):942-8
pubmed: 17541055
Child Adolesc Psychiatry Ment Health. 2021 Jan 22;15(1):3
pubmed: 33482840
J Affect Disord. 2015 Nov 1;186:249-53
pubmed: 26254616
Br J Psychiatry. 2016 Jun;208(6):548-55
pubmed: 26250744
J Atten Disord. 2011 Jan;15(1):67-78
pubmed: 19815698
PLoS One. 2015 Sep 11;10(9):e0137475
pubmed: 26360378
J Atten Disord. 2014 Jul;18(5):466-78
pubmed: 22508756
J Am Acad Child Adolesc Psychiatry. 2014 Jul;53(7):780-9.e11
pubmed: 24954827
Am J Psychiatry. 2000 May;157(5):816-8
pubmed: 10784477
Am J Psychiatry. 2008 May;165(5):604-9
pubmed: 18381904
Biol Psychiatry. 2013 Oct 15;74(8):599-606
pubmed: 23726514
BMJ Evid Based Med. 2019 Aug;24(4):155-161
pubmed: 30765384
Am J Psychiatry. 2017 Sep 1;174(9):867-876
pubmed: 28659040
J Affect Disord. 2021 May 1;286:220-227
pubmed: 33740639
Eur Child Adolesc Psychiatry. 2006 Dec;15 Suppl 1:I15-24
pubmed: 17177011
Biol Psychiatry. 2021 Jan 15;89(2):152-161
pubmed: 32753233
Eur Arch Psychiatry Clin Neurosci. 2022 Dec;272(8):1437-1442
pubmed: 35211779
Res Dev Disabil. 2012 Sep-Oct;33(5):1677-89
pubmed: 22584200
J Child Psychol Psychiatry. 2021 Sep;62(9):1132-1139
pubmed: 33543486
J Psychiatr Res. 2021 Apr;136:190-197
pubmed: 33610946
Int J Ment Health Syst. 2017 Apr 28;11:33
pubmed: 28465719
J Child Adolesc Psychopharmacol. 2013 Sep;23(7):440-7
pubmed: 24024538
Lancet Psychiatry. 2018 Sep;5(9):727-738
pubmed: 30097390
Arch Gen Psychiatry. 1983 Nov;40(11):1228-31
pubmed: 6639293
Eur Neuropsychopharmacol. 2018 Oct;28(10):1059-1088
pubmed: 30195575
Scand J Child Adolesc Psychiatr Psychol. 2020 Oct 31;8:157-165
pubmed: 33564632
J Clin Med. 2022 Jan 13;11(2):
pubmed: 35054077
BMC Psychiatry. 2013 Nov 09;13:298
pubmed: 24206839
Eur Child Adolesc Psychiatry. 2014 Jun;23(6):393-408
pubmed: 24399038
J Psychiatr Res. 2013 Aug;47(8):1019-23
pubmed: 23643104
Nat Rev Dis Primers. 2015 Aug 06;1:15020
pubmed: 27189265
J Atten Disord. 2022 Mar;26(5):735-746
pubmed: 34184907
J Child Adolesc Psychopharmacol. 2015 Aug;25(6):501-8
pubmed: 26262904
Ital J Pediatr. 2018 Sep 5;44(1):108
pubmed: 30185215
Dev Med Child Neurol. 2007 Dec;49(12):920-5
pubmed: 18039239